Martingale Asset Management L P Ligand Pharmaceuticals Inc Transaction History

Martingale Asset Management L P

$3.87 Billion
Q1 2025

A detailed history of Martingale Asset Management L P transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Martingale Asset Management L P holds 19,052 shares of LGND stock, worth $2.59 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

19,052

Previous 18,092 5.31%

Holding current value

$2.59 Million

Previous $1.94 Million 3.35%

% of portfolio

0.05%

Previous 0.05%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$105.14 - $122.23 $100,934 - $117,340	960 Added 5.31%	19,052 $2 Million
Q4 2024 Feb 13, 2025	BUY	$99.95 - $129.9 $26,986 - $35,073	270 Added 1.51%	18,092 $1.94 Million
Q3 2024 Nov 14, 2024	SELL	$82.7 - $110.11 $181,940 - $242,242	-2,200 Reduced 10.99%	17,822 $1.79 Million
Q2 2024 Aug 12, 2024	SELL	$68.53 - $87.91 $805,707 - $1.03 Million	-11,757 Reduced 37.0%	20,022 $1.69 Million
Q1 2024 May 14, 2024	SELL	$68.64 - $89.2 $12,355 - $16,056	-180 Reduced 0.56%	31,779 $2.32 Million
Q4 2023 Feb 12, 2024	SELL	$49.57 - $72.63 $8,179 - $11,983	-165 Reduced 0.51%	31,959 $2.28 Million
Q3 2023 Nov 14, 2023	BUY	$58.86 - $72.67 $226,787 - $279,997	3,853 Added 13.63%	32,124 $1.92 Million
Q2 2023 Aug 11, 2023	BUY	$69.53 - $79.33 $1.14 Million - $1.3 Million	16,380 Added 137.75%	28,271 $2.04 Million
Q1 2023 May 12, 2023	BUY	$65.67 - $77.08 $780,881 - $916,558	11,891 New	11,891 $874,000
Q2 2019 Aug 13, 2019	SELL	$107.38 - $129.34 $472,579 - $569,225	-4,401 Closed	0 $0
Q1 2019 May 08, 2019	SELL	$105.93 - $142.47 $1.23 Million - $1.65 Million	-11,601 Reduced 72.5%	4,401 $0
Q4 2018 Feb 11, 2019	SELL	$128.36 - $272.13 $38,636 - $81,911	-301 Reduced 1.85%	16,002 $2.17 Million
Q3 2018 Nov 09, 2018	BUY	$211.18 - $274.49 $211 - $274	1 Added 0.01%	16,303 $0
Q1 2018 May 11, 2018	SELL	$138.63 - $182.62 $27,726 - $36,524	-200 Reduced 1.21%	16,302 $0
Q4 2017 Feb 12, 2018	BUY	$128.36 - $147.04 $1.14 Million - $1.31 Million	8,901 Added 117.1%	16,502 $0
Q3 2017 Nov 13, 2017	BUY	$120.91 - $137.94 $919,036 - $1.05 Million	7,601	7,601 $1.04 Million

Others Institutions Holding LGND

# of Institutions

280

Shares Held

19M

Call Options Held

9.5K

Put Options Held

8.1K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.29B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.

Account

Martingale Asset Management L P Ligand Pharmaceuticals Inc Transaction History